pillbase.ru

Nexpovio

Active substance: selinexor

selinexor

Centralised EU authorisationActive

Marketing holder: Stemline Therapeutics B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 6
  • XPOVIO
    TABLET, FILM COATED · SELINEXOR 80 mg/1
    72237-105
    Karyopharm Therapeutics Inc.
  • XPOVIO
    TABLET, FILM COATED · SELINEXOR 40 mg/1
    72237-102
    Karyopharm Therapeutics Inc.
  • XPOVIO
    TABLET, FILM COATED · SELINEXOR 10 mg/1
    72237-106
    Karyopharm Therapeutics Inc.
  • XPOVIO
    TABLET, FILM COATED · SELINEXOR 20 mg/1
    72237-101
    Karyopharm Therapeutics Inc.
  • XPOVIO
    TABLET, FILM COATED · SELINEXOR 50 mg/1
    72237-103
    Karyopharm Therapeutics Inc.
All products in this country (6)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-c927-7339-857c-f109a8063b4f,01a12090-dd3a-776d-9818-4c691ac705c3,01a12095-154b-736f-aa9e-1d7b6a0e09b4,01a12097-3e25-746c-be89-01066535e383,01a12099-c1a2-7f11-9696-0e68a058d0ca;count=6 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005127
Registration status
Active
ATC code
L01XX66
Sources
  • product · EMA · EMEA/H/C/005127 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005127 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005127 · Verified 2026-10-09